Polyomic Analyses for Rational Antileishmanial Vaccine Development: A Role for Membrane Transporters?

Loading...
Thumbnail Image
Date
Authors
ABDULBASET MOHAMMADMOSTAFA F KABLI
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Leishmania parasites are transmitted by the bite of a sandfly vector, and have the ability to subvert the host immune system and adopt sophisticated strategies to develop and survive within the mammalian host. Leishmania parasites survive within macrophages, inside a parasitophorous vacuole and cause leishmaniasis. The molecular communication between host and parasite decides the outcome of infection, but is incompletely understood. Additionally, there is no vaccine currently available against human leishmaniasis, existing chemotherapies are toxic, and drug resistance is prevalent. However, leishmaniasis is vaccinable, as evidenced by acquired immunity and the availability of canine vaccines. Live attenuated Leishmania parasites can be exploited as potential vaccines that deliver prolonged immune stimulation from the native parasite niche. We have compared genotype and gene expression of an attenuated Leishmania mexicana line with a virulent, isogenic wild-type precursor. The attenuated L. mexicana (H-line) was developed by in vitro culturing the parasites under gentamicin pressure. The H-line parasites of various Leishmania species have demonstrated potential as vaccines in rodents models and dogs, and a L. major Hline is currently undergoing phase 2 and phase 3 trials in humans. Therefore, we aim to identify key virulence factors and to explore the potential of the attenuated H-line as a vaccine candidate. This study was conducted on promastigotes of L. mexicana and involved comprehensive polyomics approaches to elucidate the molecular mechanism that underpins attenuation in Leishmania parasites. Log phase promastigotes of wildtype and the gentamicin-attenuated H-line were grown in parallel and harvested for comparative polyomics analyses. For genomics, DNA was extracted and converted into DNA library for next generation sequencing. For transcriptomics, RNA was isolated and converted into a library of cDNA molecules for cluster generation and RNA sequencing. For proteomics, protein extracts were labelled using 6-plex TMT and analyzed with LC-MS/MS. For metabolomics, finger-print and foot-print metabolites were extracted with chloroform/methanol/water (1:3:1) and analyzed with LC-MS. Integration of polyomics data was carried out based on the gene ontology of the modulated omics products. Selected genes were targeted by CRISPR-Cas9 to assess their individual role in attenuation. Genomics data of the attenuated H-line revealed the presence of many gene variants and an increase of copy number in chromosomes 16 and 30, which were triploid and tetraploid, respectively. We found 481 transcripts were differentially expressed, 18 proteins differentially expressed, and 26 identified metabolites were differentially represented in the attenuated H-line Leishmania. Statistical significance thresholds in these datasets were assigned for FC ≥1.5 and FDR ≤0.05. Most of the differentially expressed proteins and transcripts were metabolic enzymes, and the majority of the differentially expressed metabolites were substrates involved in nucleotide, carbohydrate and amino acid metabolism. Based on gene ontology, correlation of polyomics datasets revealed that nucleotide metabolism was significantly altered in gentamicin-attenuated Leishmania. Interestingly, several transmembrane nutrient transporters were modulated. Nucleoside (NT1) and nucleobase (NT3) transporters were significantly down regulated in proteomics analysis. Modulation of gene expression, observed through polyomics analyses, may relate to gentamicin selection, either directly through drug selection or as an adaptive consequence of drug selection. The H-line L. mexicana and LmexΔNT3 cells become more sensitive to allopurinol, a hypoxanthine analogue, at a lower concentration (EC50= 39.1 ± 6.35 and 14.1 ± 0.65 µM, respectively, comparing to the wild-type cells (EC50
Description
Keywords
Citation
Collections